PLYMOUTH, Mass., 24 juillet 2023 /PRNewswire/ — MitoSense et le Centre for Advanced Medical Products (CAMP) sont heureux d’annoncer que MitoSense a officiellement rejoint le CAMP en tant que partenaire pour le développement de médicaments de thérapie avancée (ATMP). MitoSense, Inc. est…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.